Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of G1 Therapeutics, Inc. (GTHX) since 2017 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of G1 Therapeutics, Inc.. Table 2 shows the detailed insider transactions. This company's CIK number is 1560241.
Total stock buying since 2017: $24,259,926.
Total stock sales since 2017: $69,937,564.
Total stock option exercises since 2017: $1,464,450.
| Insider Buying | Insider Sales | Option Exercises | ||||
|---|---|---|---|---|---|---|
| Year | Shares | Value | Shares | Value | Shares | Value |
| 2024 | 0 | $0 | 187,335 | $744,201 | 28,600 | $8,580 |
| 2023 | 0 | $0 | 113,714 | $410,360 | 60,000 | $20,700 |
| 2022 | 0 | $0 | 157,646 | $1,895,051 | 142,333 | $62,903 |
| 2021 | 0 | $0 | 241,040 | $5,442,293 | 291,140 | $401,857 |
| 2020 | 59,000 | $792,326 | 92,016 | $1,839,922 | 58,500 | $166,725 |
| 2019 | 0 | $0 | 0 | $0 | 99,818 | $48,657 |
| 2018 | 4,420 | $110,105 | 1,033,392 | $48,858,989 | 225,442 | $727,128 |
| 2017 | 1,478,333 | $23,357,495 | 541,406 | $10,746,748 | 7,500 | $27,900 |
| Trading Period | Insider Buying | Insider Sales | Option Exercises | |||
|---|---|---|---|---|---|---|
| year-month | Shares | Value | Shares | Value | Shares | Value |
| 2024-07 | 0 | $0 | 17,114 | $42,920 | 0 | $0 |
| 2024-05 | 0 | $0 | 75,688 | $359,433 | 0 | $0 |
| 2024-03 | 0 | $0 | 6,547 | $19,752 | 0 | $0 |
| 2024-02 | 0 | $0 | 28,600 | $132,132 | 28,600 | $8,580 |
| 2024-01 | 0 | $0 | 59,386 | $189,964 | 0 | $0 |
| 2023-08 | 0 | $0 | 60,000 | $120,540 | 60,000 | $20,700 |
| 2023-07 | 0 | $0 | 5,796 | $14,221 | 0 | $0 |
| 2023-01 | 0 | $0 | 47,918 | $275,599 | 0 | $0 |
| 2022-10 | 0 | $0 | 15,000 | $175,485 | 15,000 | $5,850 |
| 2022-09 | 0 | $0 | 20,000 | $270,040 | 20,000 | $7,800 |
| 2022-08 | 0 | $0 | 80,000 | $1,010,879 | 80,000 | $31,200 |
| 2022-07 | 0 | $0 | 1,296 | $6,702 | 0 | $0 |
| 2022-02 | 0 | $0 | 0 | $0 | 27,333 | $18,053 |
| 2022-01 | 0 | $0 | 41,350 | $431,945 | 0 | $0 |
| 2021-11 | 0 | $0 | 0 | $0 | 40,000 | $15,600 |
| 2021-07 | 0 | $0 | 30,000 | $570,259 | 30,000 | $11,700 |
| 2021-06 | 0 | $0 | 30,000 | $659,019 | 30,000 | $11,700 |
| 2021-05 | 0 | $0 | 30,000 | $597,100 | 30,000 | $11,700 |
| 2021-04 | 0 | $0 | 45,000 | $1,064,865 | 45,000 | $17,550 |
| 2021-03 | 0 | $0 | 30,000 | $673,245 | 33,000 | $51,210 |
| 2021-02 | 0 | $0 | 31,040 | $937,930 | 31,040 | $115,468 |
| 2021-01 | 0 | $0 | 45,000 | $939,875 | 52,100 | $166,929 |
| 2020-12 | 0 | $0 | 92,016 | $1,839,922 | 39,000 | $149,130 |
| 2020-11 | 58,000 | $777,376 | 0 | $0 | 0 | $0 |
| Trade Date | Insider Name | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2024-07-05 | Umstead John W. V (Chief Financial Officer) | Sale | 527 | 2.51 | 1,321 |
| 2024-07-05 | Perry Andrew (Chief Commercial Officer) | Sale | 1,337 | 2.51 | 3,353 |
| 2024-07-05 | Bailey John E. (jack) Jr. (President and CEO) | Sale | 7,662 | 2.51 | 19,216 |
| 2024-07-05 | Avagliano Mark (Chief Business Officer) | Sale | 2,638 | 2.51 | 6,616 |
| 2024-07-05 | Malik Rajesh (Chief Medical Officer) | Sale | 2,475 | 2.51 | 6,207 |
| 2024-07-05 | Murdock Terry L (Chief Operating Officer) | Sale | 2,475 | 2.51 | 6,207 |
| 2024-05-23 | Thomas Monica R. (Chief Legal & People Officer) | Sale | 5,826 | 4.27 | 24,865 |
| 2024-05-13 | Umstead John W. V (Chief Financial Officer) | Sale | 8,151 | 4.79 | 39,035 |
| 2024-05-13 | Bailey John E. (jack) Jr. (President and CEO) | Sale | 37,258 | 4.79 | 178,428 |
| 2024-05-13 | Avagliano Mark (Chief Business Officer) | Sale | 8,151 | 4.79 | 39,035 |
| 2024-05-13 | Malik Rajesh (Chief Medical Officer) | Sale | 8,151 | 4.79 | 39,035 |
| 2024-05-13 | Murdock Terry L (Chief Operating Officer) | Sale | 8,151 | 4.79 | 39,035 |
| 2024-03-18 | Umstead John W. V (Chief Financial Officer) | Sale | 6,547 | 3.02 | 19,752 |
| 2024-02-12 | Malik Rajesh (Chief Medical Officer) | Sale | 28,600 | 4.62 | 132,132 |
| 2024-02-12 | Malik Rajesh (Chief Medical Officer) | Option Ex | 28,600 | .30 | 8,580 |
| 2024-01-04 | Umstead John W. V (Chief Financial Officer) | Sale | 111 | 2.94 | 326 |
| 2024-01-04 | Avagliano Mark (Chief Business Officer) | Sale | 721 | 2.94 | 2,121 |
| 2024-01-04 | Malik Rajesh (Chief Medical Officer) | Sale | 721 | 2.94 | 2,121 |
| 2024-01-04 | Murdock Terry L (Chief Operating Officer) | Sale | 721 | 2.94 | 2,121 |
| 2024-01-03 | Umstead John W. V (Chief Financial Officer) | Sale | 632 | 3.12 | 1,971 |
| 2024-01-03 | Perry Andrew (Chief Commercial Officer) | Sale | 2,413 | 3.12 | 7,526 |
| 2024-01-03 | Bailey John E. (jack) Jr. (President and CEO) | Sale | 11,686 | 3.12 | 36,448 |
| 2024-01-03 | Avagliano Mark (Chief Business Officer) | Sale | 3,360 | 3.12 | 10,479 |
| 2024-01-03 | Malik Rajesh (Chief Medical Officer) | Sale | 3,019 | 3.12 | 9,416 |
| 2024-01-03 | Murdock Terry L (Chief Operating Officer) | Sale | 3,019 | 3.12 | 9,416 |
| 2024-01-02 | Bailey John E. (jack) Jr. (President and CEO) | Sale | 32,983 | 3.27 | 108,019 |
| 2023-08-08 | Velleca Mark A. | Sale | 60,000 | 2.01 | 120,540 |
| 2023-08-08 | Velleca Mark A. | Option Ex | 60,000 | .34 | 20,700 |
| 2023-07-05 | Perry Andrew (Chief Commercial Officer) | Sale | 355 | 2.45 | 871 |
| 2023-07-05 | Bailey John E. (jack) Jr. (President and CEO) | Sale | 2,719 | 2.45 | 6,672 |
| 2023-07-05 | Malik Rajesh (Chief Medical Officer) | Sale | 1,361 | 2.45 | 3,339 |
| 2023-07-05 | Murdock Terry L (Chief Operating Officer) | Sale | 1,361 | 2.45 | 3,339 |
| 2023-01-05 | Hanson James S. (General Counsel) | Sale | 729 | 5.41 | 3,942 |
| 2023-01-05 | Malik Rajesh (Chief Medical Officer) | Sale | 729 | 5.41 | 3,942 |
| 2023-01-05 | Moses Jennifer K. (CFO) | Sale | 729 | 5.41 | 3,942 |
| 2023-01-05 | Murdock Terry L (Chief Operating Officer) | Sale | 729 | 5.41 | 3,942 |
| 2023-01-04 | Perry Andrew (Chief Commercial Officer) | Sale | 820 | 5.58 | 4,572 |
| 2023-01-04 | Bailey John E. (jack) Jr. (President and CEO) | Sale | 5,607 | 5.58 | 31,264 |
| 2023-01-04 | Hanson James S. (General Counsel) | Sale | 1,639 | 5.58 | 9,139 |
| 2023-01-04 | Malik Rajesh (Chief Medical Officer) | Sale | 1,639 | 5.58 | 9,139 |
| 2023-01-04 | Moses Jennifer K. (CFO) | Sale | 1,639 | 5.58 | 9,139 |
| 2023-01-04 | Murdock Terry L (Chief Operating Officer) | Sale | 1,639 | 5.58 | 9,139 |
| 2023-01-03 | Bailey John E. (jack) Jr. (President and CEO) | Sale | 32,019 | 5.85 | 187,439 |
| 2022-10-18 | Velleca Mark A. | Sale | 15,000 | 11.70 | 175,485 |
| 2022-10-18 | Velleca Mark A. | Option Ex | 15,000 | .39 | 5,850 |
| 2022-09-20 | Velleca Mark A. | Sale | 20,000 | 13.50 | 270,040 |
| 2022-09-20 | Velleca Mark A. | Option Ex | 20,000 | .39 | 7,800 |
| 2022-08-16 | Velleca Mark A. | Sale | 80,000 | 12.64 | 1,010,879 |
| 2022-08-16 | Velleca Mark A. | Option Ex | 80,000 | .39 | 31,200 |
| 2022-07-05 | Malik Rajesh (Chief Medical Officer) | Sale | 648 | 5.17 | 3,351 |
| 2022-07-05 | Murdock Terry L (Chief Operating Officer) | Sale | 648 | 5.17 | 3,351 |
| 2022-02-07 | Velleca Mark A. | Option Ex | 15,000 | .39 | 5,850 |
| 2022-02-01 | Malik Rajesh (Chief Medical Officer) | Option Ex | 10,000 | .30 | 3,000 |
| 2022-02-01 | Moses Jennifer K. (CFO) | Option Ex | 2,333 | 3.94 | 9,203 |
| 2022-01-05 | Avagliano Mark (Chief Business Officer) | Sale | 1,445 | 10.61 | 15,334 |
| 2022-01-05 | Hanson James S. (General Counsel) | Sale | 1,445 | 10.61 | 15,334 |
| 2022-01-05 | Malik Rajesh (Chief Medical Officer) | Sale | 1,445 | 10.61 | 15,334 |
| 2022-01-05 | Moses Jennifer K. (CFO) | Sale | 1,445 | 10.61 | 15,334 |
| 2022-01-05 | Murdock Terry L (Chief Operating Officer) | Sale | 1,445 | 10.61 | 15,334 |
| 2022-01-03 | Bailey John E. (jack) Jr. (President and CEO) | Sale | 34,125 | 10.41 | 355,275 |
| 2021-11-09 | Velleca Mark A. | Option Ex | 40,000 | .39 | 15,600 |
| 2021-07-15 | Velleca Mark A. | Sale | 10,000 | 18.49 | 184,899 |
| 2021-07-15 | Velleca Mark A. | Option Ex | 10,000 | .39 | 3,900 |
| 2021-07-14 | Velleca Mark A. | Sale | 10,000 | 19.08 | 190,820 |
| 2021-07-14 | Velleca Mark A. | Option Ex | 10,000 | .39 | 3,900 |
| 2021-07-13 | Velleca Mark A. | Sale | 10,000 | 19.45 | 194,540 |
| 2021-07-13 | Velleca Mark A. | Option Ex | 10,000 | .39 | 3,900 |
| 2021-06-17 | Velleca Mark A. | Sale | 10,000 | 21.77 | 217,730 |
| 2021-06-17 | Velleca Mark A. | Option Ex | 10,000 | .39 | 3,900 |
| 2021-06-16 | Velleca Mark A. | Sale | 10,000 | 21.74 | 217,380 |
| 2021-06-16 | Velleca Mark A. | Option Ex | 10,000 | .39 | 3,900 |
| 2021-06-15 | Velleca Mark A. | Sale | 10,000 | 22.39 | 223,909 |
| 2021-06-15 | Velleca Mark A. | Option Ex | 10,000 | .39 | 3,900 |
| 2021-05-13 | Velleca Mark A. | Sale | 10,000 | 20.54 | 205,410 |
| 2021-05-13 | Velleca Mark A. | Option Ex | 10,000 | .39 | 3,900 |
| 2021-05-12 | Velleca Mark A. | Sale | 10,000 | 20.07 | 200,690 |
| 2021-05-12 | Velleca Mark A. | Option Ex | 10,000 | .39 | 3,900 |
| 2021-05-11 | Velleca Mark A. | Sale | 10,000 | 19.10 | 191,000 |
| 2021-05-11 | Velleca Mark A. | Option Ex | 10,000 | .39 | 3,900 |
| 2021-04-22 | Malik Rajesh (Chief Medical Officer) | Sale | 15,000 | 22.07 | 331,095 |
| 2021-04-22 | Malik Rajesh (Chief Medical Officer) | Option Ex | 15,000 | .39 | 5,850 |
| 2021-04-15 | Velleca Mark A. | Sale | 10,000 | 24.96 | 249,630 |
| 2021-04-15 | Velleca Mark A. | Option Ex | 10,000 | .39 | 3,900 |
| 2021-04-14 | Velleca Mark A. | Sale | 10,000 | 24.53 | 245,270 |
| 2021-04-14 | Velleca Mark A. | Option Ex | 10,000 | .39 | 3,900 |
| 2021-04-13 | Velleca Mark A. | Sale | 10,000 | 23.89 | 238,870 |
| 2021-04-13 | Velleca Mark A. | Option Ex | 10,000 | .39 | 3,900 |
| 2021-03-23 | Malik Rajesh (Chief Medical Officer) | Sale | 15,000 | 21.94 | 329,055 |
| 2021-03-23 | Malik Rajesh (Chief Medical Officer) | Option Ex | 15,000 | .39 | 5,850 |
| 2021-03-03 | Moses Jennifer K. (CFO) | Option Ex | 3,000 | 3.72 | 11,160 |
| 2021-03-02 | Malik Rajesh (Chief Medical Officer) | Sale | 15,000 | 22.95 | 344,190 |
| 2021-03-02 | Malik Rajesh (Chief Medical Officer) | Option Ex | 15,000 | 2.28 | 34,200 |
| 2021-02-18 | Velleca Mark A. | Sale | 10,000 | 26.02 | 260,150 |
| 2021-02-18 | Velleca Mark A. | Option Ex | 10,000 | 3.72 | 37,200 |
| 2021-02-17 | Velleca Mark A. | Sale | 10,000 | 28.00 | 280,020 |
| 2021-02-17 | Velleca Mark A. | Option Ex | 10,000 | 3.72 | 37,200 |
| 2021-02-16 | Velleca Mark A. | Sale | 11,040 | 36.03 | 397,760 |
| 2021-02-16 | Velleca Mark A. | Option Ex | 11,040 | 3.72 | 41,068 |
| 2021-01-27 | Malik Rajesh (Chief Medical Officer) | Option Ex | 3,100 | .39 | 1,209 |
| 2021-01-22 | Malik Rajesh (Chief Medical Officer) | Sale | 15,000 | 20.64 | 309,585 |
| 2021-01-22 | Malik Rajesh (Chief Medical Officer) | Option Ex | 15,000 | 4.17 | 62,550 |
| 2021-01-21 | Velleca Mark A. | Sale | 10,000 | 20.64 | 206,400 |
| 2021-01-21 | Velleca Mark A. | Option Ex | 10,000 | 3.72 | 37,200 |
| 2021-01-20 | Velleca Mark A. | Sale | 10,000 | 21.51 | 215,110 |
| 2021-01-20 | Velleca Mark A. | Option Ex | 14,000 | 2.06 | 28,770 |
| 2021-01-19 | Velleca Mark A. | Sale | 10,000 | 20.88 | 208,780 |
| 2021-01-19 | Velleca Mark A. | Option Ex | 10,000 | 3.72 | 37,200 |
| 2020-12-24 | Rudnick Seth | Sale | 924 | 20.10 | 18,572 |
| 2020-12-23 | Rudnick Seth | Sale | 13,118 | 20.18 | 264,760 |
| 2020-12-22 | Rudnick Seth | Sale | 18,974 | 20.33 | 385,703 |
| 2020-12-17 | Velleca Mark A. (President and CEO) | Sale | 10,000 | 19.97 | 199,670 |
| 2020-12-17 | Velleca Mark A. (President and CEO) | Option Ex | 10,000 | 3.72 | 37,200 |
| 2020-12-16 | Velleca Mark A. (President and CEO) | Sale | 10,000 | 19.20 | 192,020 |
| 2020-12-16 | Velleca Mark A. (President and CEO) | Option Ex | 10,000 | 3.72 | 37,200 |
| 2020-12-15 | Velleca Mark A. (President and CEO) | Sale | 10,000 | 19.43 | 194,300 |
| 2020-12-15 | Velleca Mark A. (President and CEO) | Option Ex | 10,000 | 3.72 | 37,200 |
| 2020-12-10 | Malik Rajesh (Ch. Medical Officer & SVP R&D) | Sale | 9,000 | 20.06 | 180,549 |
| 2020-12-10 | Malik Rajesh (Ch. Medical Officer & SVP R&D) | Option Ex | 9,000 | 4.17 | 37,530 |
| 2020-12-10 | Rudnick Seth | Sale | 546 | 20.00 | 10,921 |
| 2020-12-09 | Rudnick Seth | Sale | 5,773 | 20.32 | 117,284 |
| 2020-12-08 | Rudnick Seth | Sale | 13,161 | 20.19 | 265,694 |
| 2020-12-01 | Rudnick Seth | Sale | 520 | 20.09 | 10,449 |
| 2020-11-18 | Muir Glenn P | Buy | 50,000 | 13.50 | 675,000 |
| 2020-11-11 | Bailey John E. (jack) Jr. | Buy | 4,000 | 12.83 | 51,320 |
| 2020-11-10 | Bailey John E. (jack) Jr. | Buy | 4,000 | 12.76 | 51,056 |
| 2020-09-04 | Hanson James S. (General Counsel) | Buy | 1,000 | 14.95 | 14,950 |
| 2020-03-13 | Malik Rajesh (Ch. Medical Officer & SVP R&D) | Option Ex | 2,500 | .39 | 975 |
| 2020-03-13 | Velleca Mark A. (President and CEO) | Option Ex | 3,000 | .39 | 1,170 |
| 2020-03-13 | Moses Jennifer K. (CFO) | Option Ex | 2,000 | 3.72 | 7,440 |
| 2020-01-23 | Malik Rajesh (Ch. Medical Officer & SVP R&D) | Option Ex | 5,000 | .39 | 1,950 |
| 2020-01-23 | Velleca Mark A. (President and CEO) | Option Ex | 6,000 | .39 | 2,340 |
| 2020-01-23 | Moses Jennifer K. (CFO) | Option Ex | 1,000 | 3.72 | 3,720 |
| 2019-07-18 | Moses Jennifer K. (CFO) | Option Ex | 2,000 | 3.72 | 7,440 |
| 2019-01-28 | Malik Rajesh (Ch. Medical Officer & SVP R&D) | Option Ex | 7,000 | .39 | 2,730 |
| 2019-01-17 | Velleca Mark A. (President and CEO) | Option Ex | 9,000 | .39 | 3,510 |
| 2019-01-17 | Moses Jennifer K. (VP of Finance) | Option Ex | 2,000 | 3.72 | 7,440 |
| 2019-01-02 | Strum Jay (Chief Scientific Officer) | Option Ex | 79,818 | .34 | 27,537 |
| 2018-12-26 | Hanson James S. (General Counsel) | Buy | 1,000 | 18.25 | 18,250 |
| 2018-12-26 | Schwalm Cynthia | Buy | 1,420 | 18.45 | 26,196 |
| 2018-12-17 | Malik Rajesh (Ch. Medical Officer & SVP R&D) | Sale | 3,776 | 30.00 | 113,280 |
| 2018-12-17 | Malik Rajesh (Ch. Medical Officer & SVP R&D) | Option Ex | 3,776 | 4.17 | 15,745 |
| 2018-12-10 | Demaree John (Chief Commercial Officer) | Buy | 1,000 | 33.15 | 33,151 |
| 2018-12-10 | Hanson James S. (General Counsel) | Buy | 1,000 | 32.51 | 32,508 |
| 2018-12-07 | Moses Jennifer K. (VP of Finance & Admin) | Option Ex | 2,000 | 3.72 | 7,440 |
| 2018-12-06 | Moses Jennifer K. (VP of Finance & Admin) | Sale | 750 | 34.00 | 25,500 |
| 2018-12-06 | Moses Jennifer K. (VP of Finance & Admin) | Option Ex | 750 | .39 | 292 |
| 2018-12-04 | Rudnick Seth | Sale | 10,000 | 39.65 | 396,530 |
| 2018-12-04 | Rudnick Seth | Option Ex | 10,000 | .39 | 3,900 |
| 2018-12-03 | Murdock Terry L (SVP of Development Operations) | Sale | 3,523 | 38.54 | 135,779 |
| 2018-12-03 | Murdock Terry L (SVP of Development Operations) | Option Ex | 3,523 | 13.51 | 47,595 |
| 2018-11-15 | Malik Rajesh (Ch. Medical Officer & SVP R&D) | Sale | 3,776 | 40.01 | 151,092 |
| 2018-11-15 | Malik Rajesh (Ch. Medical Officer & SVP R&D) | Option Ex | 3,776 | 4.17 | 15,745 |
| 2018-11-15 | Velleca Mark A. (President and CEO) | Sale | 5,000 | 40.22 | 201,075 |
| 2018-11-15 | Velleca Mark A. (President and CEO) | Option Ex | 5,000 | 3.72 | 18,600 |
| 2018-11-15 | Phillips Barclay A (SVP & Chief Financial Officer) | Sale | 5,000 | 39.92 | 199,590 |
| 2018-11-15 | Phillips Barclay A (SVP & Chief Financial Officer) | Option Ex | 5,000 | 19.46 | 97,300 |
| 2018-11-05 | Moses Jennifer K. (VP of Finance & Admin) | Sale | 750 | 41.38 | 31,035 |
| 2018-11-05 | Moses Jennifer K. (VP of Finance & Admin) | Option Ex | 750 | .39 | 292 |
| 2018-11-05 | Murdock Terry L (SVP of Development Operations) | Sale | 3,519 | 41.53 | 146,129 |
| 2018-11-05 | Murdock Terry L (SVP of Development Operations) | Option Ex | 3,519 | 13.51 | 47,541 |
| 2018-11-05 | Rudnick Seth | Sale | 10,000 | 41.53 | 415,349 |
| 2018-11-05 | Rudnick Seth | Option Ex | 10,000 | .39 | 3,900 |
| 2018-10-15 | Malik Rajesh (Ch. Medical Officer & SVP R&D) | Sale | 3,776 | 41.41 | 156,356 |
| 2018-10-15 | Malik Rajesh (Ch. Medical Officer & SVP R&D) | Option Ex | 10,076 | 2.28 | 22,973 |
| 2018-10-15 | Velleca Mark A. (President and CEO) | Sale | 5,000 | 41.45 | 207,270 |
| 2018-10-15 | Velleca Mark A. (President and CEO) | Option Ex | 5,000 | 3.72 | 18,600 |
| 2018-10-11 | Velleca Mark A. (President and CEO) | Option Ex | 10,000 | .39 | 3,900 |
| 2018-10-08 | Moses Jennifer K. (VP of Finance & Admin) | Sale | 750 | 44.52 | 33,390 |
| 2018-10-08 | Moses Jennifer K. (VP of Finance & Admin) | Option Ex | 750 | .39 | 292 |
| 2018-10-04 | Strum Jay (Chief Scientific Officer) | Option Ex | 850 | .30 | 255 |
| 2018-10-04 | Rudnick Seth | Sale | 10,000 | 49.82 | 498,230 |
| 2018-10-04 | Rudnick Seth | Option Ex | 10,000 | .39 | 3,900 |
| 2018-09-17 | Malik Rajesh (Ch. Medical Officer & SVP R&D) | Sale | 3,776 | 66.83 | 252,357 |
| 2018-09-17 | Malik Rajesh (Ch. Medical Officer & SVP R&D) | Option Ex | 3,776 | 4.17 | 15,745 |
| 2018-09-17 | Velleca Mark A. (President and CEO) | Sale | 5,000 | 66.87 | 334,340 |
| 2018-09-17 | Velleca Mark A. (President and CEO) | Option Ex | 5,000 | 3.72 | 18,600 |
| 2018-09-05 | Moses Jennifer K. (VP of Finance & Admin) | Sale | 750 | 59.60 | 44,700 |
| 2018-09-05 | Moses Jennifer K. (VP of Finance & Admin) | Option Ex | 2,750 | 2.06 | 5,651 |
| 2018-09-04 | Murdock Terry L (SVP of Development Operations) | Sale | 3,519 | 59.98 | 211,066 |
| 2018-09-04 | Murdock Terry L (SVP of Development Operations) | Option Ex | 3,519 | 13.51 | 47,541 |
| 2018-09-04 | Rudnick Seth | Sale | 10,000 | 60.12 | 601,200 |
| 2018-09-04 | Rudnick Seth | Option Ex | 10,000 | .39 | 3,900 |
| 2018-08-30 | Strum Jay (Chief Scientific Officer) | Sale | 5,000 | 59.66 | 298,300 |
| 2018-08-29 | Strum Jay (Chief Scientific Officer) | Sale | 5,000 | 59.63 | 298,135 |
| 2018-08-15 | Malik Rajesh (Ch. Medical Officer & SVP R&D) | Sale | 3,776 | 55.94 | 211,233 |
| 2018-08-15 | Malik Rajesh (Ch. Medical Officer & SVP R&D) | Option Ex | 3,776 | 4.17 | 15,745 |
| 2018-08-15 | Velleca Mark A. (President and CEO) | Sale | 5,000 | 55.92 | 279,615 |
| 2018-08-15 | Velleca Mark A. (President and CEO) | Option Ex | 5,000 | 3.72 | 18,600 |
| 2018-08-06 | Moses Jennifer K. (VP of Finance & Admin) | Sale | 750 | 50.79 | 38,092 |
| 2018-08-06 | Moses Jennifer K. (VP of Finance & Admin) | Option Ex | 750 | .39 | 292 |
| 2018-08-06 | Rudnick Seth | Sale | 10,000 | 50.69 | 506,900 |
| 2018-08-06 | Rudnick Seth | Option Ex | 10,000 | .39 | 3,900 |
| 2018-08-03 | Murdock Terry L (SVP of Development Operations) | Sale | 3,519 | 50.60 | 178,061 |
| 2018-08-03 | Murdock Terry L (SVP of Development Operations) | Option Ex | 3,519 | 13.51 | 47,541 |
| 2018-07-16 | Malik Rajesh (Ch. Medical Officer & SVP R&D) | Sale | 3,776 | 42.30 | 159,743 |
| 2018-07-16 | Malik Rajesh (Ch. Medical Officer & SVP R&D) | Option Ex | 3,776 | 4.17 | 15,745 |
| 2018-07-16 | Velleca Mark A. (President and CEO) | Sale | 5,000 | 42.28 | 211,424 |
| 2018-07-16 | Velleca Mark A. (President and CEO) | Option Ex | 5,000 | 3.72 | 18,600 |
| 2018-07-05 | Moses Jennifer K. (VP of Finance & Admin) | Sale | 750 | 45.66 | 34,245 |
| 2018-07-05 | Moses Jennifer K. (VP of Finance & Admin) | Option Ex | 750 | .39 | 292 |
| 2018-06-15 | Malik Rajesh (Ch. Medical Officer & SVP R&D) | Sale | 3,776 | 44.31 | 167,325 |
| 2018-06-15 | Malik Rajesh (Ch. Medical Officer & SVP R&D) | Option Ex | 3,776 | 4.17 | 15,745 |
| 2018-06-08 | Malik Rajesh (Ch. Medical Officer & SVP R&D) | Option Ex | 4,200 | .39 | 1,638 |
| 2018-06-05 | Moses Jennifer K. (VP of Finance & Admin) | Sale | 750 | 38.77 | 29,077 |
| 2018-06-05 | Moses Jennifer K. (VP of Finance & Admin) | Option Ex | 750 | .39 | 292 |
| 2018-05-31 | Velleca Mark A. (President and CEO) | Option Ex | 10,000 | .39 | 3,900 |
| 2018-05-30 | Reed Douglas Md (10% Owner) | Sale | 800,000 | 48.00 | 38,400,000 |
| 2018-05-23 | Reed Douglas Md (10% Owner) | Sale | 500 | 50.50 | 25,250 |
| 2018-05-22 | Reed Douglas Md (10% Owner) | Sale | 5,900 | 50.77 | 299,554 |
| 2018-05-21 | Reed Douglas Md (10% Owner) | Sale | 31,100 | 51.62 | 1,605,382 |
| 2018-05-15 | Malik Rajesh (Ch. Medical Officer & SVP R&D) | Sale | 3,776 | 46.48 | 175,504 |
| 2018-05-15 | Malik Rajesh (Ch. Medical Officer & SVP R&D) | Option Ex | 3,776 | 4.17 | 15,745 |
| 2018-05-15 | Velleca Mark A. (President and CEO) | Sale | 7,500 | 46.40 | 348,015 |
| 2018-05-15 | Velleca Mark A. (President and CEO) | Option Ex | 7,500 | 3.72 | 27,900 |
| 2018-05-07 | Moses Jennifer K. (VP of Finance & Admin) | Sale | 750 | 45.00 | 33,750 |
| 2018-05-07 | Moses Jennifer K. (VP of Finance & Admin) | Option Ex | 750 | .39 | 292 |
| 2018-04-16 | Malik Rajesh (Ch. Medical Officer & SVP R&D) | Sale | 3,776 | 36.33 | 137,185 |
| 2018-04-16 | Malik Rajesh (Ch. Medical Officer & SVP R&D) | Option Ex | 3,776 | 4.17 | 15,745 |
| 2018-04-16 | Velleca Mark A. (President and CEO) | Sale | 7,500 | 36.33 | 272,460 |
| 2018-04-16 | Velleca Mark A. (President and CEO) | Option Ex | 7,500 | 3.72 | 27,900 |
| 2018-04-05 | Moses Jennifer K. (VP of Finance & Admin) | Sale | 750 | 37.47 | 28,102 |
| 2018-04-05 | Moses Jennifer K. (VP of Finance & Admin) | Option Ex | 750 | .39 | 292 |
| 2018-03-15 | Malik Rajesh (Ch. Medical Officer & SVP R&D) | Sale | 3,776 | 38.18 | 144,152 |
| 2018-03-15 | Malik Rajesh (Ch. Medical Officer & SVP R&D) | Option Ex | 3,776 | 2.28 | 8,609 |
| 2018-03-15 | Velleca Mark A. (President and CEO) | Sale | 7,500 | 38.20 | 286,470 |
| 2018-03-15 | Velleca Mark A. (President and CEO) | Option Ex | 7,500 | 3.72 | 27,900 |
| 2018-03-08 | Malik Rajesh (Ch. Medical Officer & SVP R&D) | Option Ex | 4,200 | .39 | 1,638 |
| 2018-03-05 | Moses Jennifer K. (VP of Finance & Admin) | Sale | 750 | 26.55 | 19,912 |
| 2018-03-05 | Moses Jennifer K. (VP of Finance & Admin) | Option Ex | 750 | .39 | 292 |
| 2018-02-15 | Malik Rajesh (Ch. Medical Officer & SVP R&D) | Sale | 3,776 | 20.00 | 75,520 |
| 2018-02-15 | Malik Rajesh (Ch. Medical Officer & SVP R&D) | Option Ex | 3,776 | .34 | 1,302 |
| 2018-02-15 | Velleca Mark A. (President and CEO) | Sale | 7,500 | 20.00 | 150,015 |
| 2018-02-15 | Velleca Mark A. (President and CEO) | Option Ex | 7,500 | 3.72 | 27,900 |
| 2018-02-05 | Moses Jennifer K. (VP of Finance & Admin) | Sale | 750 | 22.99 | 17,242 |
| 2018-02-05 | Moses Jennifer K. (VP of Finance & Admin) | Option Ex | 750 | .39 | 292 |
| 2018-01-16 | Malik Rajesh (Ch. Medical Officer & SVP R&D) | Sale | 3,776 | 22.96 | 86,693 |
| 2018-01-16 | Malik Rajesh (Ch. Medical Officer & SVP R&D) | Option Ex | 3,776 | .30 | 1,132 |
| 2018-01-16 | Velleca Mark A. (President and CEO) | Sale | 7,500 | 22.99 | 172,395 |
| 2018-01-16 | Velleca Mark A. (President and CEO) | Option Ex | 7,500 | 3.72 | 27,900 |
| 2018-01-05 | Moses Jennifer K. (VP of Finance & Admin) | Sale | 750 | 19.96 | 14,970 |
| 2018-01-05 | Moses Jennifer K. (VP of Finance & Admin) | Option Ex | 750 | .39 | 292 |
| 2017-12-18 | Velleca Mark A. (President and CEO) | Sale | 7,500 | 20.01 | 150,105 |
| 2017-12-18 | Velleca Mark A. (President and CEO) | Option Ex | 7,500 | 3.72 | 27,900 |
| 2017-12-15 | Medimmune Ventures, Inc. (10% Owner) | Sale | 200,000 | 19.75 | 3,950,000 |
| 2017-12-01 | Medimmune Ventures, Inc. (10% Owner) | Sale | 133,906 | 19.75 | 2,644,643 |
| 2017-11-20 | Medimmune Ventures, Inc. (10% Owner) | Sale | 200,000 | 20.01 | 4,002,000 |
| 2017-11-13 | Eshelman Fredric N (Director) | Buy | 250,000 | 19.73 | 4,932,500 |
| 2017-05-22 | Eshelman Ventures, Llc (10% Owner) | Buy | 300,000 | 15.00 | 4,500,000 |
| 2017-05-22 | Kolchinsky Peter | Buy | 400,000 | 15.00 | 6,000,000 |
| 2017-05-22 | Medimmune Ventures, Inc. (10% Owner) | Buy | 75,000 | 15.00 | 1,125,000 |
| 2017-05-22 | Reed Douglas Md (10% Owner) | Buy | 133,333 | 15.00 | 1,999,995 |
| 2017-05-22 | Muir Glenn P (Director) | Buy | 20,000 | 15.00 | 300,000 |
| 2017-05-22 | Eshelman Fredric N (Director) | Buy | 300,000 | 15.00 | 4,500,000 |
Insider trading activities including stock purchases, stock sales, and option exercises of GTHX listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of G1 Therapeutics, Inc. (symbol GTHX, CIK number 1560241) see the Securities and Exchange Commission (SEC) website.